C3 and myeloid sarcoma: Similarly, anaphylatoxin C3a and C5a receptors are upregulated in patients with MS [46], and increased complement anaphylatoxin receptor-positive microglia in progressive MS patients has been suggested as a source of sustained neuroinflammatory response driving myelin and neuronal pathology [27].